A gene signature of cancer-associated fibroblasts predicts prognosis and treatment response in bladder cancer.

Xi ChenChunyan LiaoXiong ZouBei ZhangZengnan Mo

Published in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2023)

The construction of the risk model based on the CRG signature offers new avenues for the prognosis evaluation and development of personalized treatment strategies for BLCA.

Keyphrases

genome wide
copy number
extracellular matrix
dna methylation
muscle invasive bladder cancer